Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin

Carcinogenesis

Volumn 18, Issue 5, 1997, Pages 925-933

  Wang, Wei Lei ^a   Porter, Weston ^a   Burghardt, Robert ^b   Safe, Stephen H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTIMITOTIC AGENT; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR; RECEPTOR ANTIBODY; TRANSFORMING GROWTH FACTOR ALPHA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; LIGAND BINDING; ONCOGENE; PRIORITY JOURNAL; PROTEIN SECRETION;

ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BREAST NEOPLASMS; CELL DIVISION; CELL NUCLEUS; CYTOCHROME P-450 CYP1A1; DIETHYLSTILBESTROL; DNA, NEOPLASM; DNA-BINDING PROTEINS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GROWTH INHIBITORS; HUMANS; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; TETRACHLORODIBENZODIOXIN; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031426303     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.5.925     Document Type: Article

References (73)

1. Jordan, V.C. (1994) Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res. Treat., 31, 41-52.
2. Lerner, L.J. and Jordan, V.C. (1990) Development of antiestrogens and their use in breast cancer: Eighth Cain Memorial Award Lecture. Cancer Res., 50, 4177-4189.
3. Muss, H.B. (1992) Endocrine therapy for advanced breast cancer - a review. Breast Cancer Res. Treat., 21, 15-26.
4. Santen, R.J., Manni, A., Harvey, H. and Redmond, C. (1990) Endocrine treatment of breast cancer in women. Endocrine Rev., 11, 221-265.
5. El-Bayoumy, K. (1994) Evaluation of chemopreventive agents against breast cancer and proposed strategies for future clinical intervention trials. Carcinogenesis, 15, 2395-2420.
6. Gronemeyer, H., Benhamou, B., Berry, M. et al. (1992) Mechanisms of antihormone action. J. Steroid Biochem. Mol. Biol.. 41, 217-221.
7. Dickson, R.B. and Lippman, M.E. (1995) Growth factors in breast cancer. Endocrine Rev., 16, 559-589.
8. Ethier, S.P. (1995) Growth factor synthesis and human breast cancer progression. J. Natl Cancer Inst., 87, 964-973.
9. Brunner, N., Zugmaier, G., Bano, M., Ennis, B.W., Clarke, R., Cullen, K.J., Kern, F.G., Dickson, R.B. and Lippman, M.E. (1989) Endocrine therapy of human breast cancer cells: the role of secreted polypeptide growth factors. Cancer Cells, 1, 81-86.
10. Gottardis, M.M., Robinson, S.P. and Jordan, V.C. (1988) Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen. J. Steroid Biochem., 30, 311-314.
11. Shafie, S.M. and Grantham, F.H. (1981) Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic mice. J. Natl Cancer Inst., 67, 51-56.
12. Wellstein, A. (1994) Growth factor targeted and conventional therapy of breast cancer. Breast Cancer Res. Treat., 31, 141-151.
13. Callahan, R. and Salomon, D.S. (1993) Oncogenes, tumour suppressor genes and growth factors in breast cancer: novel targets for diagnosis, prognosis and therapy. Cancer Surv., 18, 35-56.
14. Safe, S. (1995) Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Ther., 67, 247-281.
15. Biegel, L. and Safe, S. (1990) Effects of 2,3,7.8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52-and 160-kDa proteins in human breast cancer cells. J. Steroid Biochem. Mol. Biol., 37, 725-732.
16. Fernandez, P. and Safe, S. (1992) Growth inhibitory and antimitogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in T47D human breast cancer cells. Toxicol. Lett., 61, 185-197.
17. R) human breast cancer cells: a unique aryl hydrocarbon (Ah)-non-responsive clone. J. Biol. Chem., 269, 11751-11759.
18. Fernandez, P., Burghardt, R., Smith, R., Nodland, K. and Safe, S. (1994) High passage T47D human breast cancer cells: altered endocrine and 2,3,7,8-tetrachlorodibenzo-p-dioxin responsiveness. Eur. J. Pharmacol., 270, 53-66.
19. Liu, H., Biegel, L., Narasimhan, T.R., Rowlands, C. and Safe, S. (1992) Inhibition of insulin-like growth factor-I responses in MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Mol. Cell. Endocrinol., 87, 19-28.
20. Krishnan, V. and Safe, S. (1993) Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships. Toxicol. Appl. Pharmacol., 120, 55-61.
21. Harper, N., Wang, X., Liu, H. and Safe, S. (1994) Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Mol. Cell. Endocrinol., 104, 47-55.
22. Krishnan, V., Porter, W., Santostefano, M., Wang, X. and Safe, S. (1995) Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells Mol. Cell. Biol., 15, 6710-6719.
23. Zacharewski, T., Bondy, K., McDonell, P. and Wu, Z.F. (1994) Anti-estrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res., 54, 2707-2713.
24. Gierthy, J.F., Lincoln, D.W., Gillespie, M.B., Seeger, J.I., Martinez, H.L., Dickerman, H.W. and Kumar, S.A. (1987) Suppression of estrogen-regulated extracellular plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res., 47, 6198-6203.
25. Kociba, R.J., Keyes, D.G., Beger, J.E., Carreon, R.M., Wade, C.E., Dittenber, D.A., Kalnins, R.P., Frauson, L.E., Park, C.L., Barnard, S.D., Hummel, R.A. and Humiston, C.G. (1978) Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol. Appl. Pharmacol., 46, 279-303.
26. Holcomb, M. and Safe, S. (1994) Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Lett., 82, 43-47.
27. Gierthy, J.F., Bennett, J.A., Bradley, L.M. and Cutler, D.S. (1993) Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res., 53, 3149-3153.
28. Astroff, B. and Safe, S. (1988) Comparative anti-estrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat. Toxicol. Appl. Pharmacol., 95, 435-443.
29. Zacharewski, T., Harris, M., Biegel, L., Morrison, V., Merchant, M. and Safe, S. (1992) 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as an antiestrogen in human and rodent cancer cell lines: evidence for the role of the Ah receptor. Toxicol. Appl. Pharmacol., 13, 311-318.
30. Astroff, B., Zacharewski, T., Safe, S., Arlotto, M.P., Parkinson, A., Thomas, P. and Levin, W. (1988) 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities. Mol. Pharmacol., 33, 231-236.
31. Safe, S. (1992) MCDF, 6-methyl-1,3,8-trichlorodibenzofuran. Drugs Future, 17, 564-565.
32. Dickerson, R., Howie-Keller, L. and Safe, S. (1995) Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies. Toxicol. Appl. Pharmacol., 135, 287-298.
33. Vickers, P.J., Dufresne, M.J. and Cowan, K.H. (1989) Relation between cytochrome P4501A1 expression and estrogen receptor content of human breast cancer cells. Mol. Endocrinol., 3, 157-164.
34. Wang, X., Thomsen, J.S., Santostefano, M., Rosengren, R., Safe, S. and Perdew, G.H. (1995) Comparative properties of the nuclear Ah receptor complex from several human cell lines. Eur. J. Pharmacol., 293, 191-205.
35. Thomsen, J.S., Nissen, L., Stacey, S.N., Hines, R.N. and Autrup, H. (1991) Differences in 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible CYP1A1 expression in human breast carcinoma cell lines involve altered transacting factors. Eur. J. Biochem., 197, 577-582.
36. Pasanen, M., Stacey, S., Lykkesfeldt, A., Briand, P., Hines, R. and Autrup, H. (1988) Induction of cytochrome P-4501A1 gene expression in human breast tumor cells. Chem.-Biol. Interactions, 66, 223-232.
37. Ivy, S.P., Tulpule, A., Fairchild, C.R., Averbuch, S.D., Myers, C.E., Nebert, D.W., Baird, W.M. and Cowan, K.H. (1988) Altered regulation of P-4501AI expression in a multidrug-resistant MCF-7 human breast cancer cell line. J. Biol. Chem., 263, 19119-19125.
38. Harris, M., Piskorska-Pliszczynska, J., Zacharewski, T., Romkes, M. and Safe, S. (1989) Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and characterization of the Ah receptor. Cancer Res., 49, 4531-4535.
39. Arellano, L.O., Wang, X. and Safe, S. (1993) Effects of cycloheximide on the induction of CYP1A1 gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in three human breast cancer cell lines. Carcinogenesis 14, 219-222.
40. Thomsen, J.S., Wang, X., Hines, R.N. and Safe, S. (1994) Restoration of Ah responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis, 15, 933-937.
41. Wang, W.L., Thomsen, J.S., Porter, W., Moore, M. and Safe, S. (1996) Effect of transient expression of the estrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells. Brit. J. Cancer, 73, 316-322.
42. Denison, M.S. and Deal, R.M. (1990) The binding of transformed aromatic hydrocarbon (Ah) receptor to its DNA recognition site is not affected by metal depletion. Mol. Cell Endocrinol., 69, 51-57.
43. Cuthill, S., Wilhelmsson, A. and Poellinger, L. (1991) Role of the ligand in intracellular receptor function: receptor affinity determines activation in vitro of the latent dioxin receptor to a DNA binding form. Mol. Cell. Biol., 11, 401-411.
44. Kumar, V. and Chambon, P. (1988) The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell, 55, 145-156.
45. Pohl, R.J. and Fouts, J.R. (1980) A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal. Biochem., 107, 150-155.
46. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
47. Duke, R.C. and Cohen, J.J. (1992) Morphological and biochemical assays of apoptosis. In Coligan, J.E., Krusibeeek, A.M., Marguiles, D.H., Shevach, E.M. and Strober, W. (eds) Current Protocols in Immunology. John Wiley and Sons, New York, pp. 3.17-3.17.16.
48. 1-450 inducers on the cell-surface receptors for epidermal growth factor, phorbol 12,13-dibutyrate, or insulin of cultured mouse hepatoma cells. J. Biol. Chem., 258, 10378-10383.
49. Hudson, L.G., Toscano, W.A. Jr and Greenlee, W.F. (1985) Regulation of epidermal growth factor binding in a human keratinocyte cell line by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol., 77, 251-259.
50. Ryan, R.P., Sunahara, G.I., Lucier, G.W., Birnbaum, L.S. and Nelson, K.G. (1989) Decreased ligand binding to the hepatic glucocorticoid and epidermal growth factor receptors after 2,3,4,7,8-pentachlorodibenzofuran and 1,2,3,4,7,8-hexachlorodibenzofuran treatment of pregnant mice. Toxicol. Appl. Pharmacol., 98, 454-464.
51. Madhukar, B.V., Brewster, D.W. and Matsumura, F. (1984) Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster. Proc. Natl Acad. Sci. USA, 81, 7407-7411.
52. Sewall, C.H., Lucier, G.W., Tritscher, A.M. and Clark, G.C. (1993) TCDD-mediated changes in hepatic epidermal growth factor receptor may be a critical event in the hepatocarcinogenic action of TCDD. Carcinogenesis, 14, 1885-1893.
53. Lin, F.H., Clark, G., Birnbaum, L.S., Lucier, G.W. and Goldstein, J.A. (1991) Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor. Mol. Pharmacol., 39, 307-313.
54. Astroff, B., Rowlands, C., Dickerson, R. and Safe, S. (1990) 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibition of 17β-estradiol-induced increases in rat uterine EGF receptor binding activity and gene expression. Mol. Cell. Endocrinol., 72, 247-252.
55. Newsted, J.L. and Giesy, J.P. (1993) Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the epidermal growth factor receptor in hepatic plasma membranes of rainbow trout. Toxicol. Appl. Pharmacol., 118, 119-130.
56. Hines, R.N., Mathis, J.M. and Jacob, C.S. (1988) Identification of multiple regulatory elements on the human cytochrome P4501A1 gene. Carcinogenesis, 9, 1599-1605.
57. Klein-Hitpass, L., Schorpp, M., Wagner, U. and Ryffel, G.U. (1986) An estrogen-responsive element derived from the 5′-flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell, 46, 1053-1061.
58. Ottaviano, Y.L., Issa, J.P., Parl, F.F., Smith, H.S., Baylin, S.B. and Davidson, N.E. (1994) Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res., 54, 2552-2555.
59. Sheikh, M.S., Shao, Z.M., Li, X.S., Dawson, M., Jetten, A.M., Wu, S., Conley, B.A., Garcia, M., Rochefort, H. and Fontana, J.A. (1994) Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-a acquire sensitivity to growth inhibition by retinoids. J. Biol. Chem., 269, 21440-21447.
60. Armstrong, D.K., Kaufmann, S.H., Ottaviano, Y.L., Furuya, Y., Buckley, J.A., Isaacs, J.T. and Davidson, N.E. (1994) Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res., 54, 5280-5283.
61. Ennis, B.W., Valverius, E.M., Bates, S.E., Lippman, M.E., Bellot, F., Kris, R., Schlessinger, J., Masui, H., Goldenberg, A. and Mendelsohn, J. (1989) Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. Mol. Endocrinol., 3, 1830-1838.
62. Filmus, J., Pollak, M.N., Cailleau, R. and Buick, R.N. (1985) MDA-MB-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem. Biophys. Res. Commun., 128, 898-905.
63. Church, J.G. and Buick, R.N. (1988) G-protein-mediated epidermal growth factor signal transduction in a human breast cancer cell line. Evidence for two intracellular pathways distinguishable by pertussis toxin. J. Biol. Chem., 263, 4242-4246.
64. Armstrong, D.K., Isaacs, J.T., Ottaviano, Y.L. and Davidson, N.E. (1992) Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468. Cancer Res., 52, 3418-3424.
65. Fernandez-Pol, J.A., Hamilton, P.D. and Klos, D.J. (1989) Transcriptional regulation of proto-oncogene expression by epidermal growth factor, transforming growth factor b1, and triiodothyronine in MDA-468 cells. J. Biol. Chem., 264, 4151-4156.
66. 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J. Biol. Chem., 267, 24591-24595.
67. Choi, E.J., Toscano, D.G., Ryan, J.A., Riedel, N. and Toscano, W.A. (1991) Dioxin induced transforming growth factor-a in human keratinocytes. J. Biol. Chem., 266, 9591-9597.
68. Vogel, C. and Abel, J. (1995) Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on growth factor expression in the human breast cancer cell line MCF-7. Arch. Toxicol., 69, 259-265.
69. Greenlee, W.F., Osborne, R., Dold, K.M., Hudson, L.G., Young, M.J. and Toscano, W.A. Jr (1987) Altered regulation of epidermal cell proliferation and differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In Hodgson, E., Bond, J.R. and Philpot, R.M. (eds) Reviews in Biochemical Toxicology. Elsevier, New York, pp. 1-35.
70. Gaido, K.W. and Maness, S.C. (1994) Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol., 127, 199-208.
71. Bates, S.E., Davidson, N.E., Valverius, E.M., Freter, C.E., Dickson, R.B., Tam, J.P., Kudlow, J.E., Lippman, M.E. and Salomon, D.S. (1988) Expression of transforming growth factor-a and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol. Endocrinol., 2, 543-555.
72. LeMaistre, C.F., Meneghetti, C., Howes, L. and Osborne, C.K. (1994) Targeting the EGF receptor in breast cancer treatment. Breast Cancer Res. Treat., 32, 97-103.
73. Reddy, K.B., Yee, D., Hilsenbeck, S.G., Coffey, R.J. and Osborne, C.K. (1994) Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression. Cell Growth Differ., 5, 1275-1282.